Chr Hansen to acquire HMO producer Jennewein for $362m
Global bioscience company Chr Hansen has signed an agreement with industrial biotechnology company Jennewein Biotechnologie to acquire its complete stake in a €310m ($362m) deal on a debt-free basis.